Cochrane Abstracts
Tenecteplase versus alteplase for acute ischemic stroke
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Tenecteplase Versus Alteplase for Acute Ischemic Stroke." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440869/all/Tenecteplase_versus_alteplase_for_acute_ischemic_stroke.
Tenecteplase versus alteplase for acute ischemic stroke. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440869/all/Tenecteplase_versus_alteplase_for_acute_ischemic_stroke. Accessed February 26, 2026.
Tenecteplase versus alteplase for acute ischemic stroke. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440869/all/Tenecteplase_versus_alteplase_for_acute_ischemic_stroke
Tenecteplase Versus Alteplase for Acute Ischemic Stroke [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440869/all/Tenecteplase_versus_alteplase_for_acute_ischemic_stroke.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tenecteplase versus alteplase for acute ischemic stroke
ID - 440869
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440869/all/Tenecteplase_versus_alteplase_for_acute_ischemic_stroke
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
